Search - tctmd.com

Displaying 21 - 37 of 37

Sort: Relevancy | Date

Presentation TCT 2017

Putting the Evidence Together: Updating Guidelines, Patient Selection, and Insurance Coverage II - Cardiology Perspective

Presenter: Robert J. Sommer, David L. Tirschwell, John D. Carroll

November 01, 2017

Presentation TCT 2017

TAVR: Current Devices and Indications

Presenter: Debabrata Mukherjee, E. Murat Tuzcu, Vinod H. Thourani

November 01, 2017

Presentation TCT 2017

Flash Debate: Based on Clinical Studies, Embolic Protection Devices Should Infrequently Be Used During TAVR

Presenter: Gilles Dreyfus, Sanjay Kaul, Duane S. Pinto

November 01, 2017

Presentation TCT 2017

FDA Perspectives: Devices to Control Hypertension - Patient Populations, Endpoints and Other Considerations

Presenter: Hiren Mistry, Michael A. Weber

October 31, 2017

Presentation TCT 2017

Use of NCDR Registries to Evaluate Race and Gender Issues Related to Medications and Devices

Presenter: Alice K. Jacobs, Spencer B. King III, John C. Messenger

October 31, 2017

Presentation TCT 2017

The BIOMODEX 3D-printed Patient Specific Models for Interventional Cardiology Planification

Presenter: Nicolo Piazza, Josep Rodés-Cabau, Thomas Marchand

October 30, 2017

Presentation TCT 2016

Devices for the Right Heart (Tricuspid and Pulmonic Valves)

Presenter: Blase A. Carabello, George D. Dangas, Colin M. Barker

November 01, 2016

Presentation TCT 2016

Opening Salvo: Despite EXCEL And NOBLE, I Don't Believe PCI Should Be the Standard Revascularization Strategy for Most Patients With Left Main CAD!

Presenter: Sanjay Kaul, Jeffrey J. Popma, John D. Puskas

November 01, 2016

Presentation TCT 2016

Return Fire: The Contrarian View - Bioresorbable Scaffolds Provide Meaningful Value for Most Patients Undergoing PCI!

Presenter: Sanjay Kaul, Jeffrey J. Popma, Michael Haude

November 01, 2016

Presentation TCT 2016

Transcatheter Mitral Valve Repair: Results With Approved Devices (US and OUS)

Presenter: Blase A. Carabello, George D. Dangas, Alec S. Vahanian

November 01, 2016

Presentation TCT 2016

Opening Salvo: I Don't Believe Bioresorbable Scaffolds Provide Meaningful Value for Most Patients Undergoing PCI!

Presenter: Sanjay Kaul, Jeffrey J. Popma, Salvatore Cassese

November 01, 2016

Presentation TCT 2016

Future TAVR Devices and Adjunctive Therapies

Presenter: Blase A. Carabello, George D. Dangas

November 01, 2016

Presentation TCT 2016

TAVR: Current Status of Devices and Indications

Presenter: Blase A. Carabello, George D. Dangas, Vinod H. Thourani

November 01, 2016

Presentation TCT 2016

Overcoming RDN Catheter Design Limitations: Issues and Spectrum of Devices

Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, Horst Sievert

October 30, 2016

Presentation Fellows 2016

Atherosclerosis, Vulnerable Plaque, and How We Evaluate Devices in the Preclinical Setting

Presenter: Kevin Croce

April 15, 2016

Presentation TCT 2015

Paravalvar Mitral Leak Closure: Indications, Devices, and an Illustrative Case

Presenter: Mohamed Chettibi, Ziyad M. Hijazi

October 11, 2015

Presentation Fellows 2015

Atherosclerosis, Vulnerable Plaque, and How We Evaluate Devices in the Preclinical Setting

Presenter: Ajay J. Kirtane, Mauricio G. Cohen, Greg L. Kaluza

May 15, 2015

Advertisement

Putting the Evidence Together: Updating Guidelines, Patient Selection, and Insurance Coverage II - Cardiology Perspective

TAVR: Current Devices and Indications

Flash Debate: Based on Clinical Studies, Embolic Protection Devices Should Infrequently Be Used During TAVR

FDA Perspectives: Devices to Control Hypertension - Patient Populations, Endpoints and Other Considerations

Use of NCDR Registries to Evaluate Race and Gender Issues Related to Medications and Devices

The BIOMODEX 3D-printed Patient Specific Models for Interventional Cardiology Planification

Devices for the Right Heart (Tricuspid and Pulmonic Valves)

Opening Salvo: Despite EXCEL And NOBLE, I Don't Believe PCI Should Be the Standard Revascularization Strategy for Most Patients With Left Main CAD!

Return Fire: The Contrarian View - Bioresorbable Scaffolds Provide Meaningful Value for Most Patients Undergoing PCI!

Transcatheter Mitral Valve Repair: Results With Approved Devices (US and OUS)

Opening Salvo: I Don't Believe Bioresorbable Scaffolds Provide Meaningful Value for Most Patients Undergoing PCI!

Future TAVR Devices and Adjunctive Therapies

TAVR: Current Status of Devices and Indications

Overcoming RDN Catheter Design Limitations: Issues and Spectrum of Devices

Atherosclerosis, Vulnerable Plaque, and How We Evaluate Devices in the Preclinical Setting

Paravalvar Mitral Leak Closure: Indications, Devices, and an Illustrative Case

Atherosclerosis, Vulnerable Plaque, and How We Evaluate Devices in the Preclinical Setting

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content